As depicted in Figure 2I, the KEGG pathways of MVO against hypertension were mainly related to neuroactive ligand–receptor interaction, the calcium signaling pathway, PI3K-Akt signaling pathway, Leishmania infection, chemical carcinogenesis, salivary secretion, and platelet activation. The gene discussed is AKT1; the disease is hypertensive disorder.